The FDA still faces hurdles in the area of painkillers.

Today, the united states Food and Medication Administration produced an announcement that may lead individuals who harbor both worries to let out a sigh of alleviation Click to read more about the treatment . The agency has asked drug makers to limit the quantity of acetaminophen to only 325 milligrams per tablet when contained in drug combinations. But actually if this latest regulatory move addresses the nagging issue of unintended acetaminophen overdose, the FDA still faces hurdles in the area of painkillers. Picture from woodleywonderworks via Flickr Innovative Commons.

Acetylon announces positive preclinical data of ricolinostat in models of lymphoma Acetylon Pharmaceuticals, Inc., the first choice in the advancement of selective histone deacetylase inhibitors for enhanced therapeutic outcomes, announced that positive preclinical data of selective HDAC6 inhibitor, ricolinostat , in types of lymphoma were presented today in an oral demonstration by Dr. Jennifer Amengual, Associate Professor of Medication & Experimental Therapeutics, Columbia University Medical Center, and in a poster session on December 8 at the 55th Annual Achieving of the American Culture of Hematology in New Orleans, LA.D., Ph.D., Professor of Medication and Experimental Therapeutics, Director of the guts for Lymphoid Malignancies, and Co-Program Director of the Lymphoid Advancement and Malignancy Program in the Herbert Irving In depth Cancer Middle at Columbia University Medical Center and Principal Investigator in another of the studies provided.